NCT03065010View on ClinicalTrials.gov

Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Breast Cancer
Interventions
DRUG

BCD-115

Inhibitor of CDK8/19

Trial Locations (1)

196153

N.N. Blokhin Russian Cancer Research Center, Saint Petersburg

Sponsors

Lead Sponsor

Biocad
All Listed Sponsors
lead

Biocad

INDUSTRY

NCT03065010 - Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter